☰

Elliott D. Kieff - Publications

Affiliations: 
Harvard University, Cambridge, MA, United States 
Area:
Molecular Biology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

289 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, ... ... Kieff E, et al. Author Correction: Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nature Microbiology. PMID 29679064 DOI: 10.1038/S41564-018-0155-1  0.447
2018 Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX, Dong XD, Li SB, Du Y, Xiong D, He JY, Li MZ, Liu YM, Zhou AJ, Zhong Q, ... ... Kieff E, et al. Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nature Microbiology. PMID 29292383 DOI: 10.1038/S41564-017-0080-8  0.588
2017 Jiang S, Zhou H, Liang J, Gerdt C, Wang C, Ke L, Schmidt SCS, Narita Y, Ma Y, Wang S, Colson T, Gewurz B, Li G, Kieff E, Zhao B. The Epstein-Barr Virus Regulome in Lymphoblastoid Cells. Cell Host & Microbe. 22: 561-573.e4. PMID 29024646 DOI: 10.1016/J.Chom.2017.09.001  0.589
2017 Ke L, Zhou H, Wang C, Xiong G, Xiang Y, Ling Y, Khabir A, Tsao GS, Zeng Y, Zeng M, Busson P, Kieff E, Guo X, Zhao B. Nasopharyngeal carcinoma super-enhancer-driven ETV6 correlates with prognosis. Proceedings of the National Academy of Sciences of the United States of America. PMID 28831010 DOI: 10.1073/Pnas.1705236114  0.514
2017 Ersing I, Nobre L, Wang LW, Soday L, Ma Y, Paulo JA, Narita Y, Ashbaugh CW, Jiang C, Grayson NE, Kieff E, Gygi SP, Weekes MP, Gewurz BE. A Temporal Proteomic Map of Epstein-Barr Virus Lytic Replication in B Cells. Cell Reports. 19: 1479-1493. PMID 28514666 DOI: 10.1016/J.Celrep.2017.04.062  0.499
2017 Minamitani T, Ma Y, Zhou H, Kida H, Tsai CY, Obana M, Okuzaki D, Fujio Y, Kumanogoh A, Zhao B, Kikutani H, Kieff E, Gewurz BE, Yasui T. Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 28351978 DOI: 10.1073/Pnas.1701836114  0.56
2016 Liang J, Zhou H, Gerdt C, Tan M, Colson T, Kaye KM, Kieff E, Zhao B. Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation. Proceedings of the National Academy of Sciences of the United States of America. PMID 27864512 DOI: 10.1073/Pnas.1616697113  0.569
2016 Hu L, Lin Z, Wu Y, Dong J, Zhao B, Cheng Y, Huang P, Xu L, Xia T, Xiong D, Wang H, Li M, Guo L, Kieff E, Zeng Y, et al. Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing. Frontiers of Medicine. PMID 26969667 DOI: 10.1007/S11684-016-0436-0  0.516
2016 Shen CL, Liu CD, You RI, Ching YH, Liang J, Ke L, Chen YL, Chen HC, Hsu HJ, Liou JW, Kieff E, Peng CW. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function. Proceedings of the National Academy of Sciences of the United States of America. PMID 26858444 DOI: 10.1073/Pnas.1525444113  0.513
2015 Minamitani T, Yasui T, Ma Y, Zhou H, Okuzaki D, Tsai CY, Sakakibara S, Gewurz BE, Kieff E, Kikutani H. Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A. Proceedings of the National Academy of Sciences of the United States of America. PMID 26305967 DOI: 10.1073/Pnas.1514484112  0.44
2015 Xiong D, Du Y, Wang HB, Zhao B, Zhang H, Li Y, Hu LJ, Cao JY, Zhong Q, Liu WL, Li MZ, Zhu XF, Tsao SW, Hutt-Fletcher LM, Song E, ... ... Kieff E, et al. Nonmuscle myosin heavy chain IIA mediates Epstein-Barr virus infection of nasopharyngeal epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 112: 11036-41. PMID 26290577 DOI: 10.1073/Pnas.1513359112  0.555
2015 Verweij FJ, de Heus C, Kroeze S, Cai H, Kieff E, Piersma SR, Jimenez CR, Middeldorp JM, Pegtel DM. Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes. Journal of Extracellular Vesicles. 4: 26334. PMID 25865256 DOI: 10.3402/Jev.V4.26334  0.388
2015 Wang HB, Zhang H, Zhang JP, Li Y, Zhao B, Feng GK, Du Y, Xiong D, Zhong Q, Liu WL, Du H, Li MZ, Huang WL, Tsao SW, Hutt-Fletcher L, ... ... Kieff E, et al. Neuropilin 1 is an entry factor that promotes EBV infection of nasopharyngeal epithelial cells. Nature Communications. 6: 6240. PMID 25670642 DOI: 10.1038/Ncomms7240  0.58
2015 Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, Liang J, Johannsen EC, Kharchenko P, Gewurz BE, Kieff E, Zhao B. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host & Microbe. 17: 205-16. PMID 25639793 DOI: 10.1016/J.Chom.2014.12.013  0.58
2015 Kang MS, Kieff E. Epstein-Barr virus latent genes. Experimental & Molecular Medicine. 47: e131. PMID 25613728 DOI: 10.1038/Emm.2014.84  0.505
2015 Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, Johannsen EC, Kieff E, Zhao B. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Proceedings of the National Academy of Sciences of the United States of America. 112: 554-9. PMID 25540416 DOI: 10.1073/Pnas.1422580112  0.606
2014 Zhao B, Barrera LA, Ersing I, Willox B, Schmidt SC, Greenfeld H, Zhou H, Mollo SB, Shi TT, Takasaki K, Jiang S, Cahir-McFarland E, Kellis M, Bulyk ML, Kieff E, et al. The NF-κB genomic landscape in lymphoblastoid B cells. Cell Reports. 8: 1595-606. PMID 25159142 DOI: 10.1016/J.Celrep.2014.07.037  0.501
2014 Hadweh P, Habelhah H, Kieff E, Mosialos G, Hatzivassiliou E. The PP4R1 subunit of protein phosphatase PP4 targets TRAF2 and TRAF6 to mediate inhibition of NF-κB activation Cellular Signalling. 26: 2730-2737. PMID 25134449 DOI: 10.1016/J.Cellsig.2014.08.001  0.389
2014 Lee EK, Kim SY, Noh KW, Joo EH, Zhao B, Kieff E, Kang MS. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome. Antiviral Research. 104: 73-83. PMID 24486954 DOI: 10.1016/J.Antiviral.2014.01.018  0.528
2014 Chen YL, Liu CD, Cheng CP, Zhao B, Hsu HJ, Shen CL, Chiu SJ, Kieff E, Peng CW. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription. Proceedings of the National Academy of Sciences of the United States of America. 111: 243-8. PMID 24344309 DOI: 10.1073/Pnas.1321800111  0.566
2014 Jiang S, Willox B, Zhou H, Holthaus AM, Wang A, Shi TT, Maruo S, Kharchenko PV, Johannsen EC, Kieff E, Zhao B. Epstein-Barr virus nuclear antigen 3C binds to BATF/IRF4 or SPI1/IRF4 composite sites and recruits Sin3A to repress CDKN2A. Proceedings of the National Academy of Sciences of the United States of America. 111: 421-6. PMID 24344258 DOI: 10.1073/Pnas.1321704111  0.5
2014 Kim JE, Kim SY, Lim SY, Kieff E, Song YJ. Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-κB activation. Molecular and Cellular Biology. 34: 325-34. PMID 24248603 DOI: 10.1128/Mcb.00912-13  0.343
2013 Portal D, Zhou H, Zhao B, Kharchenko PV, Lowry E, Wong L, Quackenbush J, Holloway D, Jiang S, Lu Y, Kieff E. Epstein-Barr virus nuclear antigen leader protein localizes to promoters and enhancers with cell transcription factors and EBNA2. Proceedings of the National Academy of Sciences of the United States of America. 110: 18537-42. PMID 24167291 DOI: 10.1073/Pnas.1317608110  0.501
2013 Liu CD, Cheng CP, Fang JS, Chen LC, Zhao B, Kieff E, Peng CW. Modulation of Epstein-Barr virus nuclear antigen 2-dependent transcription by protein arginine methyltransferase 5. Biochemical and Biophysical Research Communications. 430: 1097-102. PMID 23261437 DOI: 10.1016/J.Bbrc.2012.12.032  0.604
2012 Liu CD, Chen YL, Min YL, Zhao B, Cheng CP, Kang MS, Chiu SJ, Kieff E, Peng CW. The nuclear chaperone nucleophosmin escorts an Epstein-Barr Virus nuclear antigen to establish transcriptional cascades for latent infection in human B cells. Plos Pathogens. 8: e1003084. PMID 23271972 DOI: 10.1371/Journal.Ppat.1003084  0.636
2012 Yasui T, Sakakibara-Yada K, Nishimura T, Morita K, Tada S, Mosialos G, Kieff E, Kikutani H. Protein kinase N1, a cell inhibitor of Akt kinase, has a central role in quality control of germinal center formation. Proceedings of the National Academy of Sciences of the United States of America. 109: 21022-21027. PMID 23223530 DOI: 10.1073/Pnas.1218925110  0.357
2012 Rozenblatt-Rosen O, Deo RC, Padi M, Adelmant G, Calderwood MA, Rolland T, Grace M, Dricot A, Askenazi M, Tavares M, Pevzner SJ, Abderazzaq F, Byrdsong D, Carvunis AR, Chen AA, ... ... Kieff E, et al. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature. 487: 491-5. PMID 22810586 DOI: 10.1038/Nature11288  0.325
2012 Gulbahce N, Yan H, Dricot A, Padi M, Byrdsong D, Franchi R, Lee DS, Rozenblatt-Rosen O, Mar JC, Calderwood MA, Baldwin A, Zhao B, Santhanam B, Braun P, Simonis N, ... ... Kieff E, et al. Viral perturbations of host networks reflect disease etiology. Plos Computational Biology. 8: e1002531. PMID 22761553 DOI: 10.1371/Journal.Pcbi.1002531  0.488
2012 Kim SY, Song KA, Kieff E, Kang MS. Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization. Biochemical and Biophysical Research Communications. 424: 251-6. PMID 22735264 DOI: 10.1016/J.Bbrc.2012.06.095  0.414
2012 Gewurz BE, Towfic F, Mar JC, Shinners NP, Takasaki K, Zhao B, Cahir-McFarland ED, Quackenbush J, Xavier RJ, Kieff E. Genome-wide siRNA screen for mediators of NF-κB activation Proceedings of the National Academy of Sciences of the United States of America. 109: 2467-2472. PMID 22308454 DOI: 10.1073/Pnas.1120542109  0.492
2011 Geiser V, Cahir-McFarland E, Kieff E. Latent membrane protein 1 is dispensable for Epstein-Barr virus replication in human embryonic kidney 293 cells. Plos One. 6. PMID 21853056 DOI: 10.1371/Journal.Pone.0022929  0.545
2011 Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, Mar JC, Morton CC, Freedman ML, Blacklow SC, Aster JC, Bernstein BE, Kieff E. Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proceedings of the National Academy of Sciences of the United States of America. 108: 14902-7. PMID 21746931 DOI: 10.1073/Pnas.1108892108  0.539
2011 Wang H, Zou J, Zhao B, Johannsen E, Ashworth T, Wong H, Pear WS, Schug J, Blacklow SC, Arnett KL, Bernstein BE, Kieff E, Aster JC. Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 14908-13. PMID 21737748 DOI: 10.1073/Pnas.1109023108  0.462
2011 Xing L, Kieff E. cis-Acting Effects on RNA Processing and Drosha Cleavage Prevent Epstein-Barr Virus Latency III BHRF1 Expression Journal of Virology. 85: 8929-8939. PMID 21697496 DOI: 10.1128/Jvi.00336-11  0.368
2011 Gewurz BE, Mar JC, Padi M, Zhao B, Shinners NP, Takasaki K, Bedoya E, Zou JY, Cahir-McFarland E, Quackenbush J, Kieff E. Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation. Journal of Virology. 85: 6764-73. PMID 21543491 DOI: 10.1128/Jvi.00422-11  0.537
2011 Verweij FJ, Van Eijndhoven MAJ, Hopmans ES, Vendrig T, Wurdinger T, Cahir-Mcfarland E, Kieff E, Geerts D, Van Der Kant R, Neefjes J, Middeldorp JM, Pegtel DM. LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation Embo Journal. 30: 2115-2129. PMID 21527913 DOI: 10.1038/Emboj.2011.123  0.418
2011 Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E. EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding. Proceedings of the National Academy of Sciences of the United States of America. 108: 7808-13. PMID 21518914 DOI: 10.1073/Pnas.1104991108  0.542
2011 Calderwood MA, Lee S, Holthaus AM, Blacklow SC, Kieff E, Johannsen E. Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth. Virology. 414: 19-25. PMID 21440926 DOI: 10.1016/J.Virol.2011.02.018  0.364
2011 Maruo S, Zhao B, Johannsen E, Kieff E, Zou J, Takada K. Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression Proceedings of the National Academy of Sciences of the United States of America. 108: 1919-1924. PMID 21245331 DOI: 10.1073/Pnas.1019599108  0.548
2011 Kang MS, Lee EK, Soni V, Lewis TA, Koehler AN, Srinivasan V, Kieff E. Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance. Journal of Virology. 85: 2859-68. PMID 21209116 DOI: 10.1128/Jvi.01628-10  0.388
2011 Zhao B, Mar JC, Maruo S, Lee S, Gewurz BE, Johannsen E, Holton K, Rubio R, Takada K, Quackenbush J, Kieff E. Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines. Proceedings of the National Academy of Sciences of the United States of America. 108: 337-42. PMID 21173222 DOI: 10.1073/Pnas.1017419108  0.508
2010 Boehm D, Gewurz BE, Kieff E, Cahir-McFarland E. Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133–224 or 373–419 Proceedings of the National Academy of Sciences of the United States of America. 107: 18103-18108. PMID 20923877 DOI: 10.1073/Pnas.1011752107  0.425
2009 Lee S, Sakakibara S, Maruo S, Zhao B, Calderwood MA, Holthaus AM, Lai CY, Takada K, Kieff E, Johannsen E. Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. Journal of Virology. 83: 12368-77. PMID 19776126 DOI: 10.1128/Jvi.01403-09  0.506
2009 Maruo S, Wu Y, Ito T, Kanda T, Kieff ED, Takada K. Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proceedings of the National Academy of Sciences of the United States of America. 106: 4419-24. PMID 19237563 DOI: 10.1073/Pnas.0813134106  0.383
2009 Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, ... ... Kieff E, et al. The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Research. 19: 438-51. PMID 19208682 DOI: 10.1101/Gr.083550.108  0.398
2008 Song Y, Izumi KM, Shinners NP, Gewurz BE, Kieff E. IRF7 activation by Epstein–Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3 Proceedings of the National Academy of Sciences of the United States of America. 105: 18448-18453. PMID 19017798 DOI: 10.1073/Pnas.0809933105  0.407
2008 Kang MS, Soni V, Bronson R, Kieff E. Epstein-barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice Journal of Virology. 82: 4180-4183. PMID 18256159 DOI: 10.1128/Jvi.02596-07  0.328
2007 Soni V, Cahir-McFarland E, Kieff E. LMP1 TRAFficking activates growth and survival pathways Advances in Experimental Medicine and Biology. 597: 173-187. PMID 17633026 DOI: 10.1007/978-0-387-70630-6_14  0.469
2007 Calderwood MA, Venkatesan K, Xing L, Chase MR, Vazquez A, Holthaus AM, Ewence AE, Li N, Hirozane-Kishikawa T, Hill DE, Vidal M, Kieff E, Johannsen E. Epstein-Barr virus and virus human protein interaction maps. Proceedings of the National Academy of Sciences of the United States of America. 104: 7606-11. PMID 17446270 DOI: 10.1073/Pnas.0702332104  0.386
2007 Peng CW, Zhao B, Chen HC, Chou ML, Lai CY, Lin SZ, Hsu HY, Kieff E. Hsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2. Blood. 109: 5447-54. PMID 17341665 DOI: 10.1182/Blood-2006-08-040634  0.534
2007 Hatzivassiliou EG, Kieff E, Mosialos G. Constitutive CD40 signaling phenocopies the transforming function of the Epstein-Barr virus oncoprotein LMP1 in vitro. Leukemia Research. 31: 315-320. PMID 16919331 DOI: 10.1016/J.Leukres.2006.06.023  0.345
2007 Xing L, Kieff E. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication Journal of Virology. 81: 9967-9975. DOI: 10.1128/Jvi.02244-06  0.33
2006 Portal D, Rosendorff A, Kieff E. Epstein–Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4 Proceedings of the National Academy of Sciences of the United States of America. 103: 19278-19283. PMID 17159145 DOI: 10.1073/Pnas.0609320103  0.379
2006 Chen A, Zhao B, Kieff E, Aster JC, Wang F. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Journal of Virology. 80: 10139-50. PMID 17005691 DOI: 10.1128/Jvi.00854-06  0.578
2006 Soni V, Yasui T, Cahir-McFarland E, Kieff E. LMP1 Transmembrane Domain 1 and 2 (TM1-2) FWLY Mediates Intermolecular Interactions with TM3-6 To Activate NF-κB Journal of Virology. 80: 10787-10793. PMID 16928765 DOI: 10.1128/Jvi.01214-06  0.335
2006 Rosendorff A, Sakakibara S, Lu S, Kieff E, Xuan Y, DiBacco A, Shi Y, Shi Y, Gill G. NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proceedings of the National Academy of Sciences of the United States of America. 103: 5308-13. PMID 16567619 DOI: 10.1073/Pnas.0601066103  0.323
2006 Song YJ, Jen KY, Soni V, Kieff E, Cahir-McFarland E. IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation. Proceedings of the National Academy of Sciences of the United States of America. 103: 2689-94. PMID 16477006 DOI: 10.1073/Pnas.0511096103  0.395
2006 Yuan J, Cahir-McFarland E, Zhao B, Kieff E. Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication Journal of Virology. 80: 2548-2565. PMID 16474161 DOI: 10.1128/Jvi.80.5.2548-2565.2006  0.512
2006 Zhao B, Maruo S, Cooper A, Chase MR, Johannsen E, Kieff E, Cahir-McFarland E. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines Proceedings of the National Academy of Sciences of the United States of America. 103: 1900-1905. PMID 16446431 DOI: 10.1073/Pnas.0510612103  0.554
2006 Tzimas C, Michailidou G, Arsenakis M, Kieff E, Mosialos G, Hatzivassiliou EG. Human ubiquitin specific protease 31 is a deubiquitinating enzyme implicated in activation of nuclear factor-κB Cellular Signalling. 18: 83-92. PMID 16214042 DOI: 10.1016/J.Cellsig.2005.03.017  0.365
2005 Ling PD, Peng RS, Nakajima A, Yu JH, Tan J, Moses SM, Yang WH, Zhao B, Kieff E, Bloch KD, Bloch DB. Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. The Embo Journal. 24: 3565-75. PMID 16177824 DOI: 10.1038/Sj.Emboj.7600820  0.526
2005 Maruo S, Johannsen E, Illanes D, Cooper A, Zhao B, Kieff E. Epstein-Barr virus nuclear protein 3A domains essential for growth of lymphoblasts: transcriptional regulation through RBP-Jkappa/CBF1 is critical. Journal of Virology. 79: 10171-9. PMID 16051810 DOI: 10.1128/Jvi.79.16.10171-10179.2005  0.507
2005 Rainio EM, Ahlfors H, Carter KL, Ruuska M, Matikainen S, Kieff E, Koskinen PJ. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity Virology. 333: 201-206. PMID 15721354 DOI: 10.1016/J.Virol.2005.01.001  0.5
2005 Kang MS, Lu H, Yasui T, Sharpe A, Warren H, Cahir-McFarland E, Bronson R, Hung SC, Kieff E. Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice. Proceedings of the National Academy of Sciences of the United States of America. 102: 820-5. PMID 15640350 DOI: 10.1073/Pnas.0408774102  0.346
2004 Lee S, Andrieu C, Saltel F, Destaing O, Auclair J, Pouchkine V, Michelon J, Salaun B, Kobayashi R, Jurdic P, Kieff ED, Sylla BS. IkappaB kinase beta phosphorylates Dok1 serines in response to TNF, IL-1, or gamma radiation. Proceedings of the National Academy of Sciences of the United States of America. 101: 17416-21. PMID 15574499 DOI: 10.1073/Pnas.0408061101  0.305
2004 Johannsen E, Luftig M, Chase MR, Weicksel S, Cahir-McFarland E, Illanes D, Sarracino D, Kieff E. Proteins of purified Epstein-Barr virus. Proceedings of the National Academy of Sciences of the United States of America. 101: 16286-91. PMID 15534216 DOI: 10.1073/Pnas.0407320101  0.701
2004 Peng CW, Zhao B, Kieff E. Four EBNA2 domains are important for EBNALP coactivation. Journal of Virology. 78: 11439-42. PMID 15452270 DOI: 10.1128/Jvi.78.20.11439-11442.2004  0.502
2004 Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. Journal of Virology. 78: 4108-19. PMID 15047827 DOI: 10.1128/Jvi.78.8.4108-4119.2004  0.469
2004 Peng CW, Xue Y, Zhao B, Johannsen E, Kieff E, Harada S. Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation. Proceedings of the National Academy of Sciences of the United States of America. 101: 1033-8. PMID 14732686 DOI: 10.1073/Pnas.0307808100  0.571
2004 Yasui T, Luftig M, Soni V, Kieff E. Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling Proceedings of the National Academy of Sciences of the United States of America. 101: 278-283. PMID 14695890 DOI: 10.1073/Pnas.2237224100  0.686
2004 Luftig M, Yasui T, Soni V, Kang MS, Jacobson N, Cahir-McFarland E, Seed B, Kieff E. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proceedings of the National Academy of Sciences of the United States of America. 101: 141-6. PMID 14691250 DOI: 10.1073/Pnas.2237183100  0.693
2004 Rosendorff A, Illanes D, David G, Lin J, Kieff E, Johannsen E. EBNA3C coactivation with EBNA2 requires a SUMO homology domain. Journal of Virology. 78: 367-377. PMID 14671118 DOI: 10.1128/Jvi.78.1.367-377.2004  0.47
2003 Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh WC, Li X, Akira S, Suzuki N, Suzuki S, Mosialos G, Kieff E. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. Proceedings of the National Academy of Sciences of the United States of America. 100: 15595-600. PMID 14673102 DOI: 10.1073/Pnas.2136756100  0.694
2003 Maruo S, Johannsen E, Illanes D, Cooper A, Kieff E. Epstein-Barr Virus Nuclear Protein EBNA3A Is Critical for Maintaining Lymphoblastoid Cell Line Growth Journal of Virology. 77: 10437-10447. PMID 12970429 DOI: 10.1128/Jvi.77.19.10437-10447.2003  0.408
2003 Cooper A, Johannsen E, Maruo S, Cahir-McFarland E, Illanes D, Davidson D, Kieff E. EBNA3A association with RBP-Jkappa down-regulates c-myc and Epstein-Barr virus-transformed lymphoblast growth. Journal of Virology. 77: 999-1010. PMID 12502816 DOI: 10.1128/Jvi.77.2.999-1010.2003  0.439
2002 Carter KL, Cahir-McFarland E, Kieff E. Epstein-Barr virus-induced changes in B-lymphocyte gene expression Journal of Virology. 76: 10427-10436. PMID 12239319 DOI: 10.1128/Jvi.76.20.10427-10436.2002  0.501
2002 Yang J, Aittomäki S, Pesu M, Carter K, Saarinen J, Kalkkinen N, Kieff E, Silvennoinen O. Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II. The Embo Journal. 21: 4950-8. PMID 12234934 DOI: 10.1093/Emboj/Cdf463  0.362
2002 Han I, Xue Y, Harada S, Orstavik S, Skalhegg B, Kieff E. Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins Molecular and Cellular Biology. 22: 2136-2146. PMID 11884601 DOI: 10.1128/Mcb.22.7.2136-2146.2002  0.493
2002 Cahir-McFarland E, Kieff E. NF-κB Inhibition in EBV-Transformed Lymphoblastoid Cell Lines Recent Results in Cancer Research. 159: 44-48. PMID 11785843 DOI: 10.1007/978-3-642-56352-2_6  0.424
2002 Higuchi M, Kieff E, Izumi KM. The Epstein-Barr Virus Latent Membrane Protein 1 Putative Janus Kinase 3 (JAK3) Binding Domain Does Not Mediate JAK3 Association or Activation in B-Lymphoma or Lymphoblastoid Cell Lines Journal of Virology. 76: 455-459. PMID 11739714 DOI: 10.1128/Jvi.76.1.455-459.2002  0.475
2002 Lin J, Johannsen E, Robertson E, Kieff E. Epstein-Barr Virus Nuclear Antigen 3C Putative Repression Domain Mediates Coactivation of the LMP1 Promoter with EBNA-2 Journal of Virology. 76: 232-242. PMID 11739688 DOI: 10.1128/Jvi.76.1.232-242.2002  0.452
2001 Kang MS, Hung SC, Kieff E. Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growth. Proceedings of the National Academy of Sciences of the United States of America. 98: 15233-8. PMID 11734622 DOI: 10.1073/Pnas.211556598  0.485
2001 Higuchi M, Izumi KM, Kieff E. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proceedings of the National Academy of Sciences of the United States of America. 98: 4675-4680. PMID 11296297 DOI: 10.1073/Pnas.081075298  0.45
2001 Luftig MA, Cahir-McFarland E, Mosialos G, Kieff E. Effects of the NIK aly Mutation on NF-κB Activation by the Epstein-Barr Virus Latent Infection Membrane Protein, Lymphotoxin β Receptor, and CD40 Journal of Biological Chemistry. 276: 14602-14606. PMID 11278268 DOI: 10.1074/Jbc.C100103200  0.68
2001 Harada S, Yalamanchili R, Kieff E. Epstein-Barr Virus Nuclear Protein 2 Has at Least Two N-Terminal Domains That Mediate Self-Association Journal of Virology. 75: 2482-2487. PMID 11160754 DOI: 10.1128/Jvi.75.5.2482-2487.2001  0.411
2001 Han I, Harada S, Weaver D, Xue Y, Lane W, Orstavik S, Skalhegg B, Kieff E. EBNA-LP associates with cellular proteins including DNA-PK and HA95. Journal of Virology. 75: 2475-2481. PMID 11160753 DOI: 10.1128/Jvi.75.5.2475-2481.2001  0.494
2001 Hung SC, Kang M, Kieff E. Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1 Proceedings of the National Academy of Sciences of the United States of America. 98: 1865-1870. DOI: 10.1073/Pnas.98.4.1865  0.388
2000 Baron S, Poast J, Rizzo D, McFarland E, Kieff E. Electroporation of antibodies, DNA, and other macromolecules into cells: a highly efficient method. Journal of Immunological Methods. 242: 115-126. PMID 10986394 DOI: 10.1016/S0022-1759(00)00242-8  0.365
2000 Sylla BS, Murphy K, Cahir-McFarland E, Lane WS, Mosialos G, Kieff E. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-κB Proceedings of the National Academy of Sciences of the United States of America. 97: 7470-7475. PMID 10852966 DOI: 10.1073/Pnas.130193097  0.435
2000 Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E. NF-κB inhibition causes spontaneous apoptosis in Epstein-Barr virus- transformed lymphoblastoid cells Proceedings of the National Academy of Sciences of the United States of America. 97: 6055-6060. PMID 10811897 DOI: 10.1073/Pnas.100119497  0.443
2000 Ørstavik S, Eide T, Collas P, Han I, Taskén K, Kieff E, Jahnsen T, Sklhegg BS. Identification, cloning and characterization of a novel nuclear protein, HA95, homologous to A-kinase anchoring protein 95⋆ Biology of the Cell. 92: 27-37. PMID 10761695 DOI: 10.1016/S0248-4900(00)88761-4  0.366
2000 Callahan J, Aster J, Sklar J, Kieff E, Robertson ES. Intracellular forms of human NOTCH1 interact at distinctly different levels with RBP-jkappa in human B and T cells Leukemia. 14: 84-92. PMID 10637481 DOI: 10.1038/Sj.Leu.2401630  0.46
2000 Wang L, Grossman SR, Kieff E. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proceedings of the National Academy of Sciences of the United States of America. 97: 430-5. PMID 10618435 DOI: 10.1073/Pnas.97.1.430  0.411
1999 Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, Habermann TM, Wiesner RH, Swinnen LJ, Woodle ES, Bromberg JS. Epstein-barr virus-induced posttransplant lymphoproliferative disorders Transplantation. 68: 1517-1525. PMID 10589949 DOI: 10.1097/00007890-199911270-00015  0.327
1999 Izumi KM, McFarland EC, Riley EA, Rizzo D, Chen Y, Kieff E. The residues between the two transformation effector sites of Epstein- Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation Journal of Virology. 73: 9908-9916. PMID 10559303 DOI: 10.1128/Jvi.73.12.9908-9916.1999  0.483
1999 Goldmacher VS, Bartle LM, Skaletskaya A, Dionne CA, Kedersha NL, Vater CA, Han JW, Lutz RJ, Watanabe S, Cahir McFarland ED, Kieff ED, Mocarski ES, Chittenden T. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2 Proceedings of the National Academy of Sciences of the United States of America. 96: 12536-12541. PMID 10535957 DOI: 10.1073/Pnas.96.22.12536  0.559
1999 Ye H, Park YC, Kreishman M, Kieff E, Wu H. The Structural Basis for the Recognition of Diverse Receptor Sequences by TRAF2 Molecular Cell. 4: 321-330. PMID 10518213 DOI: 10.1016/S1097-2765(00)80334-2  0.301
1999 Izumi KM, Cahir McFarland ED, Ting AT, Riley EA, Seed B, Kieff ED. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation. Molecular and Cellular Biology. 19: 5759-67. PMID 10409763 DOI: 10.1128/Mcb.19.8.5759  0.47
1999 Lee H, Choi J, Li M, Kaye K, Kieff E, Jung JU. Role of Cellular Tumor Necrosis Factor Receptor-Associated Factors in NF-κB Activation and Lymphocyte Transformation by Herpesvirus Saimiri STP Journal of Virology. 73: 3913-3919. PMID 10196286 DOI: 10.1128/Jvi.73.5.3913-3919.1999  0.367
1999 Kube D, Vockerodt M, Weber O, Hell K, Wolf J, Haier B, Grässer FA, Müller-Lantzsch N, Kieff E, Diehl V, Tesch H. Expression of Epstein-Barr Virus Nuclear Antigen 1 Is Associated with Enhanced Expression of CD25 in the Hodgkin Cell Line L428 Journal of Virology. 73: 1630-1636. PMID 9882370 DOI: 10.1128/Jvi.73.2.1630-1636.1999  0.364
1999 Kaye KM, Izumi KM, Li H, Johannsen E, Davidson D, Longnecker R, Kieff E. An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently Initiates Primary B-Lymphocyte Growth Transformation Journal of Virology. 73: 10525-10530. DOI: 10.1128/Jvi.73.12.10525-10530.1999  0.478
1998 Harada S, Yalamanchili R, Kieff E. Residues 231 to 280 of the Epstein-Barr Virus Nuclear Protein 2 Are Not Essential for Primary B-Lymphocyte Growth Transformation Journal of Virology. 72: 9948-9954. PMID 9811732 DOI: 10.1128/Jvi.72.12.9948-9954.1998  0.52
1998 Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. Journal of Virology. 72: 7900-8. PMID 9733827 DOI: 10.1128/Jvi.72.10.7900-7908.1998  0.48
1998 Kieff E. Current Perspectives on the Molecular Pathogenesis of Virus-Induced Cancers in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome Journal of the National Cancer Institute Monographs. 1998: 7-14. PMID 9709295 DOI: 10.1093/Oxfordjournals.Jncimonographs.A024177  0.368
1998 Sylla BS, Hung SC, Davidson DM, Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E, Mosialos G. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta. Proceedings of the National Academy of Sciences of the United States of America. 95: 10106-11. PMID 9707608 DOI: 10.1073/Pnas.95.17.10106  0.401
1998 Kieff E, Shenk T. Modulation of apoptosis by herpesviruses Seminars in Virology. 8: 471-480. DOI: 10.1006/Smvy.1998.0151  0.326
1997 Izumi KM, Kieff ED. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB Proceedings of the National Academy of Sciences of the United States of America. 94: 12592-12597. PMID 9356494 DOI: 10.1073/Pnas.94.23.12592  0.503
1997 Devergne O, Birkenbach M, Kieff E. Epstein–Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin Proceedings of the National Academy of Sciences of the United States of America. 94: 12041-12046. PMID 9342359 DOI: 10.1073/Pnas.94.22.12041  0.371
1997 Harada S, Kieff E. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. Journal of Virology. 71: 6611-6618. PMID 9261383 DOI: 10.1128/Jvi.71.9.6611-6618.1997  0.426
1997 Chatila T, Ho N, Liu P, Liu S, Mosialos G, Kieff E, Speck SH. The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication. Journal of Virology. 71: 6560-7. PMID 9261377 DOI: 10.1128/Jvi.71.9.6560-6567.1997  0.459
1997 Rochford R, Miller CL, Cannon MJ, Izumi KM, Kieff E, Longnecker R. In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2). Archives of Virology. 142: 707-20. PMID 9170499 DOI: 10.1007/S007050050113  0.463
1997 VanArsdale TL, VanArsdale SL, Force WR, Walter BN, Mosialos G, Kieff E, Reed JC, Ware CF. Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB. Proceedings of the National Academy of Sciences of the United States of America. 94: 2460-5. PMID 9122217 DOI: 10.1073/Pnas.94.6.2460  0.306
1997 Aster JC, Robertson ES, Hasserjian RP, Turner JR, Kieff E, Sklar J. Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jκ or nuclear localization sequences retain the ability to associate with RBP-Jκ and activate transcription Journal of Biological Chemistry. 272: 11336-11343. PMID 9111040 DOI: 10.1074/Jbc.272.17.11336  0.4
1997 Izumi KM, Kaye KM, Kieff ED. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation Proceedings of the National Academy of Sciences of the United States of America. 94: 1447-1452. PMID 9037073 DOI: 10.1073/Pnas.94.4.1447  0.494
1997 Miller WE, Mosialos G, Kieff E, Raab-Traub N. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation. Journal of Virology. 71: 586-94. PMID 8985387 DOI: 10.1128/Jvi.71.1.586-594.1997  0.411
1996 Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Molecular and Cellular Biology. 16: 7098-108. PMID 8943365 DOI: 10.1128/Mcb.16.12.7098  0.443
1996 Ansieau S, Scheffrahn I, Mosialos G, Brand H, Duyster J, Kaye K, Harada J, Dougall B, Hübinger G, Kieff E, Herrmann F, Leutz A, Gruss H. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Proceedings of the National Academy of Sciences of the United States of America. 93: 14053-14058. PMID 8943059 DOI: 10.1073/Pnas.93.24.14053  0.337
1996 Ishida T, Mizushima Si, Azuma S, Kobayashi N, Tojo T, Suzuki K, Aizawa S, Watanabe T, Mosialos G, Kieff E, Yamamoto T, Inoue J. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. The Journal of Biological Chemistry. 271: 28745-8. PMID 8910514 DOI: 10.1074/Jbc.271.46.28745  0.359
1996 Franken M, Devergne O, Rosenzweig M, Annis B, Kieff E, Wang F. Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. Journal of Virology. 70: 7819-26. PMID 8892903 DOI: 10.1128/Jvi.70.11.7819-7826.1996  0.482
1996 Robertson ES, Ooka T, Kieff ED. Epstein-Barr virus vectors for gene delivery to B lymphocytes Proceedings of the National Academy of Sciences of the United States of America. 93: 11334-11340. PMID 8876136 DOI: 10.1073/Pnas.93.21.11334  0.471
1996 Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-κB activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein Proceedings of the National Academy of Sciences of the United States of America. 93: 11085-11090. PMID 8855313 DOI: 10.1073/Pnas.93.20.11085  0.392
1996 Johannsen E, Miller CL, Grossman SR, Kieff E. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJkappa in Epstein-Barr virus-transformed B lymphocytes. Journal of Virology. 70: 4179-83. PMID 8648764 DOI: 10.1128/Jvi.70.6.4179-4183.1996  0.459
1996 Yalamanchili R, Harada S, Kieff E. The N-terminal half of EBNA2, except for seven prolines, is not essential for primary B-lymphocyte growth transformation. Journal of Virology. 70: 2468-2473. PMID 8642674 DOI: 10.1128/Jvi.70.4.2468-2473.1996  0.364
1996 Robertson ES, Lin J, Kieff E. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJκ Journal of Virology. 70: 3068-3074. PMID 8627785 DOI: 10.1128/Jvi.70.5.3068-3074.1996  0.481
1996 Devergne O, Hummel M, Koeppen H, Le Beau MM, Nathanson EC, Kieff E, Birkenbach M. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. Journal of Virology. 70: 1143-53. PMID 8551575 DOI: 10.1128/Jvi.70.2.1143-1153.1996  0.5
1995 Tong X, Wang F, Thut CJ, Kieff E. The Epstein-Barr Virus Nuclear Protein 2 Acidic Domain Can Interact with TFIIB, TAF40, and RPA70 but Not with TATA-Binding Protein Journal of Virology. 69: 585-588. PMID 7983760 DOI: 10.1128/Jvi.69.1.585-588.1995  0.432
1995 Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1. Journal of Virology. 69: 253-62. PMID 7983717 DOI: 10.1128/Jvi.69.1.253-262.1995  0.424
1995 Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, Bolen JB, Kieff E. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity. 2: 155-66. PMID 7895172 DOI: 10.1016/S1074-7613(95)80040-9  0.397
1995 Robertson E, Kieff E. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. Journal of Virology. 69: 983-93. PMID 7815566 DOI: 10.1128/Jvi.69.2.983-993.1995  0.496
1995 Kieff E. Editorial: Epstein-Barr Virus: New Insights The Journal of Infectious Diseases. 171: 1323-1324. PMID 7751710 DOI: 10.1093/Infdis/171.5.1323  0.435
1995 Kurilla MG, Heineman T, Davenport LC, Kieff E, Hutt-Fletcher LM. A novel Epstein-Barr virus glycoprotein gp150 expressed from the BDLF3 open reading frame. Virology. 209: 108-21. PMID 7747461 DOI: 10.1006/Viro.1995.1235  0.454
1995 Tong X, Drapkin R, Reinberg D, Kieff E. The 62- and 80-kDa subunits of transcription factor IIH mediate the interaction with Epstein-Barr virus nuclear protein 2. Proceedings of the National Academy of Sciences of the United States of America. 92: 3259-63. PMID 7724549 DOI: 10.1073/Pnas.92.8.3259  0.407
1995 Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein Jκ Journal of Virology. 69: 3108-3116. PMID 7707539 DOI: 10.1128/Jvi.69.5.3108-3116.1995  0.449
1995 Tong X, Drapkin R, Yalamanchili R, Mosialos G, Kieff E. The Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIE Molecular and Cellular Biology. 15: 4735-4744. PMID 7651391 DOI: 10.1128/Mcb.15.9.4735  0.398
1995 Kieff E. Epstein-Barr virus--increasing evidence of a link to carcinoma. The New England Journal of Medicine. 333: 724-726. PMID 7637753 DOI: 10.1056/Nejm199509143331110  0.345
1995 Mannick JB, Tong X, Hemnes A, Kieff E. The Epstein-Barr virus nuclear antigen leader protein associates with hsp72/hsc73. Journal of Virology. 69: 8169-8172. PMID 7494344 DOI: 10.1128/Jvi.69.12.8169-8172.1995  0.425
1995 Kaye KM, Izumi KM, Mosialos G, Kieff E. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. Journal of Virology. 69: 675-683. DOI: 10.1128/Jvi.69.2.675-683.1995  0.473
1995 Kieff E, Robertson E, Kaye K, Izumi K, Miller C, Yalamanchili R, Harada S, Grossman S, Tong X, VanArsdale T, Ware C, Drabkin R, Reinberg D, Mosialos G. Mechanisms of gene regulation and transformation by epstein barr virus Journal of Cancer Research and Clinical Oncology. 121: S17-S17. DOI: 10.1007/Bf02559821  0.404
1994 Miller CL, Lee JH, Kieff E, Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proceedings of the National Academy of Sciences of the United States of America. 91: 772-6. PMID 8290598 DOI: 10.1073/Pnas.91.2.772  0.472
1994 Izumi KM, Kaye KM, Kieff ED. Epstein-Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation Journal of Virology. 68: 4369-4376. PMID 8207810 DOI: 10.1128/Jvi.68.7.4369-4376.1994  0.398
1994 Alfieri C, Allison AC, Kieff E. Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes. Antimicrobial Agents and Chemotherapy. 38: 126-129. PMID 8141564 DOI: 10.1128/Aac.38.1.126  0.49
1994 Mosialos G, Hanissian SH, Jawahar S, Vara L, Kieff E, Chatila TA. A Ca2+/calmodulin-dependent protein kinase, CaM kinase-Gr, expressed after transformation of primary human B lymphocytes by Epstein-Barr virus (EBV) is induced by the EBV oncogene LMP1. Journal of Virology. 68: 1697-1705. PMID 8107230 DOI: 10.1128/Jvi.68.3.1697-1705.1994  0.432
1994 Robertson ES, Tomkinson B, Kieff E. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro Journal of Virology. 68: 1449-1458. PMID 8107208 DOI: 10.1128/Jvi.68.3.1449-1458.1994  0.505
1994 Tong X, Yalamanchili R, Harada S, Kieff E. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains. Journal of Virology. 68: 6188-6197. PMID 8083959 DOI: 10.1128/Jvi.68.10.6188-6197.1994  0.388
1994 Grossman SR, Johannsen E, Tong X, Yalamanchili R, Kieff E. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein. Proceedings of the National Academy of Sciences of the United States of America. 91: 7568-72. PMID 8052621 DOI: 10.1073/Pnas.91.16.7568  0.424
1994 Argaet VP, Schmidt CW, Burrows SR, Silins SL, Kurilla MG, Doolan DL, Suhrbier A, Moss DJ, Kieff E, Sculley TB, Misko IS. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. Journal of Experimental Medicine. 180: 2335-2340. PMID 7964506 DOI: 10.1084/Jem.180.6.2335  0.428
1994 Yalamanchili R, Tong X, Grossman S, Johannsen E, Mosialos G, Kieff E. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Virology. 204: 634-41. PMID 7941331 DOI: 10.1006/Viro.1994.1578  0.501
1994 Mosialos G, Yamashiro S, Baughman RW, Matsudaira P, Vara L, Matsumura F, Kieff E, Birkenbach M. Epstein-Barr virus infection induces expression in B lymphocytes of a novel gene encoding an evolutionarily conserved 55-kilodalton actin-bundling protein. Journal of Virology. 68: 7320-8. PMID 7933116 DOI: 10.1128/Jvi.68.11.7320-7328.1994  0.463
1994 Sample J, Kieff EF, Kieff ED. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes Journal of General Virology. 75: 2741-2746. PMID 7931160 DOI: 10.1099/0022-1317-75-10-2741  0.412
1994 Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation Cell. 79: 1137-1146. PMID 7528106 DOI: 10.1016/0092-8674(94)90005-1  0.492
1993 Tomkinson B, Robertson E, Kieff E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. Journal of Virology. 67: 2014-25. PMID 8445720 DOI: 10.1128/Jvi.67.4.2014-2025.1993  0.403
1993 Kaye KM, Izumi KM, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation Proceedings of the National Academy of Sciences of the United States of America. 90: 9150-9154. PMID 8415670 DOI: 10.1073/Pnas.90.19.9150  0.465
1993 Longnecker R, Miller CL, Tomkinson B, Miao XQ, Kieff E. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. Journal of Virology. 67: 5068-74. PMID 8392630 DOI: 10.1128/Jvi.67.8.5068-5074.1993  0.515
1993 Birkenbach M, Josefsen K, Yalamanchili R, Lenoir G, Kieff E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. Journal of Virology. 67: 2209-2220. PMID 8383238 DOI: 10.1128/Jvi.67.4.2209-2220.1993  0.482
1993 Longnecker R, Miller CL, Miao XQ, Tomkinson B, Kieff E. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. Journal of Virology. 67: 2006-13. PMID 8383224 DOI: 10.1128/Jvi.67.4.2006-2013.1993  0.506
1993 Kurilla MG, Swaminathan S, Welsh RM, Kieff E, Brutkiewicz RR. Effects of virally expressed interleukin-10 on vaccinia virus infection in mice Journal of Virology. 67: 7623-7628. PMID 8230481 DOI: 10.1128/Jvi.67.12.7623-7628.1993  0.401
1993 Tomkinson B, Robertson E, Yalamanchili R, Longnecker R, Kieff E. Epstein-Barr virus recombinants from overlapping cosmid fragments. Journal of Virology. 67: 7298-7306. PMID 8230453 DOI: 10.1128/Jvi.67.12.7298-7306.1993  0.46
1993 Durda PJ, Sullivan M, Kieff E, Pearson GR, Rabin H. An Enzyme-Linked Immunosorbent Assay for the Measurement of Human IgA Antibody Responses to Epstein-Barr Virus Membrane Antigen Intervirology. 36: 11-19. PMID 8225907 DOI: 10.1159/000150317  0.33
1993 Swaminathan S, Hesselton R, Sullivan J, Kieff E. Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. Journal of Virology. 67: 7406-7413. PMID 7693971 DOI: 10.1128/Jvi.67.12.7406-7413.1993  0.476
1993 Miller CL, Longnecker R, Kieff E. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. Journal of Virology. 67: 3087-94. PMID 7684459 DOI: 10.1128/Jvi.67.6.3087-3094.1993  0.444
1993 Marchini A, Kieff E, Longnecker R. Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation. Journal of Virology. 67: 606-609. DOI: 10.1128/Jvi.67.1.606-609.1993  0.497
1992 Birkenbach M, Tong X, Bradbury LE, Tedder TF, Kieff E. Characterization of an Epstein-Barr virus receptor on human epithelial cells. Journal of Experimental Medicine. 176: 1405-1414. PMID 1383386 DOI: 10.1084/Jem.176.5.1405  0.417
1992 Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ. Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. Journal of Experimental Medicine. 176: 169-176. PMID 1377222 DOI: 10.1084/Jem.176.1.169  0.418
1992 Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. Journal of Virology. 66: 7461-7468. PMID 1331531 DOI: 10.1128/Jvi.66.12.7461-7468.1992  0.492
1992 Longnecker R, Miller CL, Miao XQ, Marchini A, Kieff E. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. Journal of Virology. 66: 6461-9. PMID 1328675 DOI: 10.1128/Jvi.66.11.6461-6469.1992  0.499
1992 Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 89: 5862-6. PMID 1321426 DOI: 10.1073/Pnas.89.13.5862  0.393
1992 Burkhardt AL, Bolen JB, Kieff E, Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. Journal of Virology. 66: 5161-5167. PMID 1321296 DOI: 10.1128/Jvi.66.8.5161-5167.1992  0.412
1992 Swaminathan S, Huneycutt BS, Reiss CS, Kieff E. Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes. Journal of Virology. 66: 5133-5136. PMID 1321292 DOI: 10.1128/Jvi.66.8.5133-5136.1992  0.456
1992 Marchini A, Longnecker R, Kieff E. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants. Journal of Virology. 66: 4972-4981. PMID 1321281 DOI: 10.1128/Jvi.66.8.4972-4981.1992  0.52
1992 Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB. Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV- positive malignancies Journal of Experimental Medicine. 176: 157-168. PMID 1319456 DOI: 10.1084/Jem.176.1.157  0.474
1992 Liebowitz D, Mannick J, Takada K, Kieff E. Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. Journal of Virology. 66: 4612-6. PMID 1318423 DOI: 10.1128/Jvi.66.7.4612-4616.1992  0.419
1992 Marchini A, Cohen JI, Wang F, Kieff E. A selectable marker allows investigation of a nontransforming Epstein-Barr virus mutant Journal of Virology. 66: 3214-3219. PMID 1313925 DOI: 10.1128/Jvi.66.5.3214-3219.1992  0.504
1992 Tomkinson B, Kieff E. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. Journal of Virology. 66: 2893-2903. PMID 1313908 DOI: 10.1128/Jvi.66.5.2893-2903.1992  0.51
1992 Tomkinson B, Kieff E. Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection. Journal of Virology. 66: 780-789. PMID 1309912 DOI: 10.1128/Jvi.66.2.780-789.1992  0.425
1991 Cohen JI, Wang F, Kieff E. Epstein-Barr Virus Nuclear Protein 2 Mutations Define Essential Domains for Transformation and Transactivation Journal of Virology. 65: 2545-2554. PMID 1850028 DOI: 10.1128/Jvi.65.5.2545-2554.1991  0.458
1991 Alfieri C, Birkenbach MP, Kieff E. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 181: 595-608. PMID 1849678 DOI: 10.1016/0042-6822(91)90893-G  0.511
1991 Wang F, Marchini A, Kieff E. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells. Journal of Virology. 65: 1701-1709. PMID 1848303 DOI: 10.1128/Jvi.65.4.1701-1709.1991  0.485
1991 Swaminathan S, Tomkinson B, Kieff E. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro Proceedings of the National Academy of Sciences of the United States of America. 88: 1546-1550. PMID 1847527 DOI: 10.1073/Pnas.88.4.1546  0.478
1991 Longnecker R, Druker B, Roberts TM, Kieff E. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. Journal of Virology. 65: 3681-92. PMID 1710288 DOI: 10.1128/Jvi.65.7.3681-3692.1991  0.46
1991 Sample C, Kieff E. Molecular basis for Epstein-Barr virus induced pathogenesis and disease Springer Seminars in Immunopathology. 13: 133-146. PMID 1664982 DOI: 10.1007/Bf00201464  0.815
1991 Mannick JB, Cohen JI, Birkenbach MP, Marchini A, Kieff E. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. Journal of Virology. 65: 6826-6837. PMID 1658376 DOI: 10.1128/Jvi.65.12.6826-6837.1991  0.521
1991 Tsang S, Wang F, Izumi KM, Kieff E. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression. Journal of Virology. 65: 6765-6771. PMID 1658373 DOI: 10.1128/Jvi.65.12.6765-6771.1991  0.433
1991 Marchini A, Tomkinson B, Cohen JI, Kieff E. BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensable for B-lymphocyte transformation and virus replication Journal of Virology. 65: 5991-6000. PMID 1656084 DOI: 10.1128/Jvi.65.11.5991-6000.1991  0.531
1991 Cohen JI, Kieff E. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator Journal of Virology. 65: 5880-5885. PMID 1656076 DOI: 10.1128/Jvi.65.11.5880-5885.1991  0.49
1991 Wang F, Kikutani H, Tsang S, Kishimoto T, Kieff E. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. Journal of Virology. 65: 4101-4106. PMID 1649318 DOI: 10.1128/Jvi.65.8.4101-4106.1991  0.459
1991 Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site Proceedings of the National Academy of Sciences of the United States of America. 88: 6343-6347. PMID 1648738 DOI: 10.1073/Pnas.88.14.6343  0.821
1991 Henderson S, Rowe M, Gregory C, Croom-Carter D, Wang F, Longnecker R, Kieff E, Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 65: 1107-1115. PMID 1648447 DOI: 10.1016/0092-8674(91)90007-L  0.537
1991 Alfieri C, Birkenbach M, Kieff E. Erratum: Early events in Epstein-Barr virus infection of human B lymphocytes (Virology (1991) 181 (595-608)) Virology. 185. DOI: 10.1016/0042-6822(91)90579-Z  0.428
1990 Wang F, Tsang S, Kurilla MG, Cohen JI, Kieff E. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. Journal of Virology. 64: 3407-3416. PMID 2352328 DOI: 10.1128/Jvi.64.7.3407-3416.1990  0.54
1990 Mallon R, Borkowski J, Albin R, Pepitoni S, Schwartz J, Kieff E. The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5′ long terminal repeat Journal of Virology. 64: 6282-6285. PMID 2173793 DOI: 10.1128/Jvi.64.12.6282-6285.1990  0.322
1990 Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. Journal of Virology. 64: 4084-92. PMID 2166806 DOI: 10.1128/Jvi.64.9.4084-4092.1990  0.436
1990 Petti L, Sample C, Kieff E. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins Virology. 176: 563-574. PMID 2161150 DOI: 10.1016/0042-6822(90)90027-O  0.795
1990 Murray RJ, Kurilla MG, Griffin HM, Mackett M, Arrand JR, Rowe M, Burrows SR, Moss DJ, Kieff E, Rickinson AB. Human cytotoxic T-cell responses against Epstein-Barr virus nuclear antigens demonstrated by using recombinant vaccinia viruses Proceedings of the National Academy of Sciences of the United States of America. 87: 2906-2910. PMID 2158098 DOI: 10.1073/Pnas.87.8.2906  0.505
1990 Longnecker R, Kieff E. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. Journal of Virology. 64: 2319-2326. PMID 2157888 DOI: 10.1128/Jvi.64.5.2319-2326.1990  0.475
1990 Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 Journal of Virology. 64: 2309-2318. PMID 2157887 DOI: 10.1128/Jvi.64.5.2309-2318.1990  0.776
1990 Ghosh D, Kieff E. cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site. Journal of Virology. 64: 1855-1858. PMID 2157069 DOI: 10.1128/Jvi.64.4.1855-1858.1990  0.493
1990 Sample J, Kieff E. Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes Journal of Virology. 64: 1667-1674. PMID 2157049 DOI: 10.1128/Jvi.64.4.1667-1674.1990  0.412
1990 Gong M, Kieff E. Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110 Journal of Virology. 64: 1507-1516. PMID 2157039 DOI: 10.1128/Jvi.64.4.1507-1516.1990  0.348
1989 Liebowitz D, Kieff E. Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin. Journal of Virology. 63: 4051-4054. PMID 2668563 DOI: 10.1128/Jvi.63.9.4051-4054.1989  0.478
1989 Cohen JI, Wang F, Mannick J, Kieff E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation Proceedings of the National Academy of Sciences of the United States of America. 86: 9558-9562. PMID 2556717 DOI: 10.1073/Pnas.86.23.9558  0.46
1989 Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E, Cohen JI. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease New England Journal of Medicine. 321: 1080-1085. PMID 2552313 DOI: 10.1056/Nejm198910193211604  0.477
1989 Birkenbach M, Liebowitz D, Wang F, Sample J, Kieff E. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines Journal of Virology. 63: 4079-4084. PMID 2548016 DOI: 10.1128/Jvi.63.9.4079-4084.1989  0.519
1989 Serafini-Cessi F, Malagolini N, Nanni M, Dall'Olio F, Campadelli-Fiume G, Tanner J, Kieff E. Characterization of N- and O-linked oligosaccharides of glycoprotein 350 from Epstein-Barr virus. Virology. 170: 1-10. PMID 2541535 DOI: 10.1016/0042-6822(89)90345-0  0.315
1989 Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. Journal of Virology. 63: 1031-1039. PMID 2536817 DOI: 10.1128/Jvi.63.3.1031-1039.1989  0.418
1989 Sample J, Liebowitz D, Kieff E. Two related Epstein-Barr virus membrane proteins are encoded by separate genes Journal of Virology. 63: 933-937. PMID 2536113 DOI: 10.1128/Jvi.63.2.933-937.1989  0.45
1989 Kieff E, Liebowitz D. 10 Oncogenesis by Herpesviruses Cold Spring Harbor Monograph Archive. 18: 259-280. DOI: 10.1101/087969336.18.259  0.486
1988 Gordon J, Millsum MJ, Finney M, Cairns JA, Guy GR, Gregory CD, Abbot SD, Rickinson AB, Wang F, Kieff E. Altered growth phenotype of a Burkitt's lymphoma line following the introduction and stable expression of the EBNA 2A gene. Current Topics in Microbiology and Immunology. 141: 149-56. PMID 3215047 DOI: 10.1007/978-3-642-74006-0_20  0.376
1988 Wang D, Liebowitz D, Wang F, Gregory C, Rickinson A, Larson R, Springer T, Kieff E. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. Journal of Virology. 62: 4173-4184. PMID 2845129 DOI: 10.1128/Jvi.62.11.4173-4184.1988  0.502
1988 Murray RJ, Wang D, Young LS, Wang F, Rowe M, Kieff E, Rickinson AB. Epstein-Barr virus-specific cytotoxic T-cell recognition of transfectants expressing the virus-coded latent membrane protein LMP Journal of Virology. 62: 3747-3755. PMID 2843672 DOI: 10.1128/Jvi.62.10.3747-3755.1988  0.485
1988 Wang D, Liebowitz D, Kieff E. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. Journal of Virology. 62: 2337-2346. PMID 2836616 DOI: 10.1128/Jvi.62.7.2337-2346.1988  0.492
1988 Petti L, Sample J, Wang F, Kieff E. A fifth Epstein-Barr virus nuclear protein (EBNA3C) is expressed in latently infected growth-transformed lymphocytes Journal of Virology. 62: 1330-1338. PMID 2831394 DOI: 10.1128/Jvi.62.4.1330-1338.1988  0.475
1988 Heineman T, Gong M, Sample J, Kieff E. Identification of the Epstein-Barr virus gp85 gene Journal of Virology. 62: 1101-1107. PMID 2831372 DOI: 10.1128/Jvi.62.4.1101-1107.1988  0.45
1988 Tanner J, Whang Y, Sample J, Sears A, Kieff E. Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes Journal of Virology. 62: 4452-4464. PMID 2460635 DOI: 10.1128/Jvi.62.12.4452-4464.1988  0.371
1987 Liebowitz D, Kopan R, Fuchs E, Sample J, Kieff E. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Molecular and Cellular Biology. 7: 2299-308. PMID 3039344 DOI: 10.1128/Mcb.7.7.2299  0.504
1987 Schultz LD, Tanner J, Hofmann KJ, Emini EA, Condra JH, Jones RE, Kieff E, Ellis RW. Expression and secretion in yeast of a 400-kDa envelope glycoprotein derived from Epstein-Barr virus. Gene. 54: 113-23. PMID 3038696 DOI: 10.1016/0378-1119(87)90353-2  0.406
1987 Tanner J, Weis J, Fearon D, Whang Y, Kieff E. Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis Cell. 50: 203-213. PMID 3036369 DOI: 10.1016/0092-8674(87)90216-9  0.388
1987 Lowe RS, Keller PM, Keech BJ, Davison AJ, Whang Y, Morgan AJ, Kieff E, Ellis RW. Varicella-zoster virus as a live vector for the expression of foreign genes Proceedings of the National Academy of Sciences of the United States of America. 84: 3896-3900. PMID 3035557 DOI: 10.1073/Pnas.84.11.3896  0.469
1987 Wang F, Gregory CD, Rowe M, Rickinson AB, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proceedings of the National Academy of Sciences of the United States of America. 84: 3452-3456. PMID 3033649 DOI: 10.1073/Pnas.84.10.3452  0.5
1987 Whang Y, Silberklang M, Morgan A, Munshi S, Lenny AB, Ellis RW, Kieff E. Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells. Journal of Virology. 61: 1796-1807. PMID 3033311 DOI: 10.1128/Jvi.61.6.1796-1807.1987  0.433
1987 Wang F, Petti L, Braun D, Seung S, Kieff E. A bicistronic Epstein-Barr virus mRNA encodes two nuclear proteins in latently infected, growth-transformed lymphocytes. Journal of Virology. 61: 945-954. PMID 3029429 DOI: 10.1128/Jvi.61.4.945-954.1987  0.494
1987 Gong M, Ooka T, Matsuo T, Kieff E. Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB. Journal of Virology. 61: 499-508. PMID 3027378 DOI: 10.1128/Jvi.61.2.499-508.1987  0.494
1987 Pearson GR, Luka J, Petti L, Sample J, Birkenbach M, Braun D, Kieff E. Identification of an Epstein-Barr virus early gene encoding a second component of the restricted early antigen complex Virology. 160: 151-161. PMID 2820125 DOI: 10.1016/0042-6822(87)90055-9  0.467
1987 Rowe M, Evans HS, Young LS, Hennessy K, Kieff E, Rickinson AB. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells Journal of General Virology. 68: 1575-1586. PMID 2438376 DOI: 10.1099/0022-1317-68-6-1575  0.509
1986 Sample J, Hummel M, Braun D, Birkenbach M, Kieff E. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: A probable transcriptional initiation site Proceedings of the National Academy of Sciences of the United States of America. 83: 5096-5100. PMID 3460083 DOI: 10.1073/Pnas.83.14.5096  0.399
1986 Szigeti R, Timar L, Weiland O, Henle W, Henle G, Hennessy K, Kieff E, Sulitzeanu D, Dillner J, Klein G. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells. Clinical Immunology and Immunopathology. 41: 342-50. PMID 3022972 DOI: 10.1016/0090-1229(86)90005-X  0.463
1986 Hennessy K, Wang F, Bushman EW, Kieff E. Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family Proceedings of the National Academy of Sciences of the United States of America. 83: 5693-5697. PMID 3016714 DOI: 10.1073/Pnas.83.15.5693  0.488
1986 Liebowitz D, Wang D, Kieff E. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. Journal of Virology. 58: 233-237. PMID 3005654 DOI: 10.1128/Jvi.58.1.233-237.1986  0.399
1986 Sulitzeanu D, Szigeti R, Klein G, Hennessy K, Kieff E. Leukocyte migration inhibition demonstrates a human T-cell response to a membrane protein expressed in latent Epstein-Barr virus infection Journal of Virology. 58: 230-232. PMID 3005653 DOI: 10.1128/Jvi.58.1.230-232.1986  0.479
1986 Hummel M, Arsenakis M, Marchini A, Lee LA, Roizman B, Kieff E. Herpes simplex virus expressing Epstein-Barr virus nuclear antigen 1 Virology. 148: 337-348. PMID 3002038 DOI: 10.1016/0042-6822(86)90330-2  0.605
1986 Dambaugh T, Wang F, Hennessy K, Woodland E, Rickinson A, Kieff E. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells Journal of Virology. 59: 453-462. PMID 2426468 DOI: 10.1128/Jvi.59.2.453-462.1986  0.51
1985 Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells Cell. 43: 831-840. PMID 3000618 DOI: 10.1016/0092-8674(85)90256-9  0.46
1985 Hennessy K, Fennewald S, Kieff E. A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus Proceedings of the National Academy of Sciences of the United States of America. 82: 5944-5948. PMID 2994055 DOI: 10.1073/Pnas.82.17.5944  0.485
1985 Beisel C, Tanner J, Matsuo T, Thorley-Lawson D, Kezdy F, Kieff E. Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene. Journal of Virology. 54: 665-74. PMID 2987520 DOI: 10.1128/Jvi.54.3.665-674.1985  0.416
1985 Heller M, Flemington E, Kieff E, Deininger P. Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat. Molecular and Cellular Biology. 5: 457-65. PMID 2985954 DOI: 10.1128/Mcb.5.3.457  0.363
1985 Hennessy K, Kieff E. A second nuclear protein is encoded by Epstein-Barr virus in latent infection Science. 227: 1238-1240. PMID 2983420 DOI: 10.1126/Science.2983420  0.526
1984 Hummel M, Thorley-Lawson D, Kieff E. An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200). Journal of Virology. 49: 413-7. PMID 6319741 DOI: 10.1128/Jvi.49.2.413-417.1984  0.387
1984 Dambaugh T, Hennessy K, Chamnankit L, Kieff E. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2 Proceedings of the National Academy of Sciences of the United States of America. 81: 7632-7636. PMID 6209719 DOI: 10.1073/Pnas.81.23.7632  0.473
1984 Luka J, Kreofsky T, Pearson GR, Hennessy K, Kieff E. Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen Journal of Virology. 52: 833-838. PMID 6208381 DOI: 10.1128/Jvi.52.3.833-838.1984  0.392
1984 Matsuo T, Heller M, Petti L, O'Shiro E, Kieff E. Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science. 226: 1322-1325. PMID 6095452 DOI: 10.1126/Science.6095452  0.447
1984 Hennessy K, Fennewald S, Hummel M, Cole T, Kieff E. A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection Proceedings of the National Academy of Sciences of the United States of America. 81: 7207-7211. PMID 6095274 DOI: 10.1073/Pnas.81.22.7207  0.472
1984 Volsky DJ, Gross T, Sinangil F, Kuszynski C, Bartzatt R, Dambaugh T, Kieff E. Expression of Epstein-Barr virus (EBV) DNA and cloned DNA fragments in human lymphocytes following Sendai virus envelope-mediated gene transfer Proceedings of the National Academy of Sciences of the United States of America. 81: 5926-5930. PMID 6091119 DOI: 10.1073/Pnas.81.19.5926  0.428
1984 Fennewald S, Santen Vv, Kieff E. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. Journal of Virology. 51: 411-419. PMID 6086953 DOI: 10.1128/Jvi.51.2.411-419.1984  0.408
1983 Hennessy K, Kieff E. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain Proceedings of the National Academy of Sciences of the United States of America. 80: 5665-5669. PMID 6310587 DOI: 10.1073/Pnas.80.18.5665  0.502
1983 Pearson GR, Vroman B, Chase B, Sculley T, Hummel M, Kieff E. Identification of polypeptide components of the Epstein-Barr virus early antigen complex with monoclonal antibodies. Journal of Virology. 47: 193-201. PMID 6306272 DOI: 10.1128/Jvi.47.1.193-201.1983  0.375
1983 Hennessy K, Heller M, Van Santen V, Kieff E. Simple repeat array in Epstein-Barr virus DNA encodes part of the Epstein-Barr nuclear antigen Science. 220: 1396-1398. PMID 6304878 DOI: 10.1126/Science.6304878  0.475
1983 Henderson A, Ripley S, Heller M, Kieff E. Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proceedings of the National Academy of Sciences of the United States of America. 80: 1987-1991. PMID 6300885 DOI: 10.1073/Pnas.80.7.1987  0.415
1983 Santen Vv, Cheung A, Hummel M, Kieff E. RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells. Journal of Virology. 46: 424-433. PMID 6188862 DOI: 10.1128/Jvi.46.2.424-433.1983  0.355
1982 Heller M, Henderson A, Kieff E. Repeat array in Epstein-Barr virus DNA is related to cell DNA sequences interspersed on human chromosomes Proceedings of the National Academy of Sciences of the United States of America. 79: 5916-5920. PMID 6310555 DOI: 10.1073/Pnas.79.19.5916  0.364
1982 Dambaugh TR, Kieff E. Identification and nucleotide sequences of two similar tandem direct repeats in Epstein-Barr virus DNA. Journal of Virology. 44: 823-833. PMID 6294332 DOI: 10.1128/Jvi.44.3.823-833.1982  0.417
1982 Heller M, Santen Vv, Kieff E. Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections. Journal of Virology. 44: 311-320. PMID 6292493 DOI: 10.1128/Jvi.44.1.311-320.1982  0.472
1982 Cheung A, Kieff E. Long internal direct repeat in Epstein-Barr virus DNA Journal of Virology. 44: 286-294. PMID 6292491 DOI: 10.1128/Jvi.44.1.286-294.1982  0.321
1982 King W, Dambaugh T, Heller M, Dowling J, Kieff E. Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion. Journal of Virology. 43: 979-986. PMID 6292475 DOI: 10.1128/Jvi.43.3.979-986.1982  0.312
1982 Hummel M, Kieff E. Mapping of polypeptides encoded by the Epstein-Barr virus genome in productive infection Proceedings of the National Academy of Sciences of the United States of America. 79: 5698-5702. PMID 6291060 DOI: 10.1073/Pnas.79.18.5698  0.468
1982 Kieff E, Dambaugh T, Heller M, King W, Cheung A, van Santen V, Hummel M, Beisel C, Fennewald S, Hennessy K, Heineman T. The biology and chemistry of Epstein-Barr virus. The Journal of Infectious Diseases. 146: 506-17. PMID 6288806 DOI: 10.1093/Infdis/146.4.506  0.454
1982 Heller M, Gerber P, Kieff E. DNA of herpesvirus pan, a third member of the Epstein-Barr virus-Herpesvirus papio group. Journal of Virology. 41: 931-939. PMID 6284982 DOI: 10.1128/Jvi.41.3.931-939.1982  0.353
1982 Hummel M, Kieff E. Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells. Journal of Virology. 43: 262-272. PMID 6180174 DOI: 10.1128/Jvi.43.1.262-272.1982  0.405
1981 Cheung A, Kieff E. Epstein-Barr virus DNA. X. Direct repeat within the internal direct repeat of Epstein-Barr virus DNA. Journal of Virology. 40: 501-507. PMID 6275099 DOI: 10.1128/Jvi.40.2.501-507.1981  0.356
1981 Heller M, Dambaugh T, Kieff E. Epstein-Barr virus DNA. IX. Variation among viral DNAs from producer and nonproducer infected cells. Journal of Virology. 38: 632-648. PMID 6264134 DOI: 10.1128/Jvi.38.2.632-648.1981  0.348
1981 Heller M, Kieff E. Colinearity between the DNAs of Epstein-Barr virus and herpesvirus papio. Journal of Virology. 37: 821-826. PMID 6261021 DOI: 10.1128/Jvi.37.2.821-826.1981  0.307
1981 Heller M, Gerber P, Kieff E. Herpesvirus papio DNA is similar in organization to Epstein-Barr virus DNA. Journal of Virology. 37: 698-709. PMID 6261014 DOI: 10.1128/Jvi.37.2.698-709.1981  0.303
1981 King W, Santen VV, Kieff E. Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells. Journal of Virology. 38: 649-660. PMID 6165836 DOI: 10.1128/Jvi.38.2.649-660.1981  0.329
1981 Santen VV, Cheung A, Kieff E. Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line Proceedings of the National Academy of Sciences of the United States of America. 78: 1930-1934. PMID 6112750 DOI: 10.1073/Pnas.78.3.1930  0.329
1980 Dambaugh T, Raab-Traub N, Heller M, Beisel C, Hummel M, Cheung A, Fennewald S, King W, Kieff E. Variations among isolates of Epstein-Barr virus. Annals of the New York Academy of Sciences. 354: 309-25. PMID 6261649 DOI: 10.1111/J.1749-6632.1980.Tb27974.X  0.379
1980 King W, Thomas-Powell AL, Raab-Traub N, Hawke M, Kieff E. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line. Journal of Virology. 36: 506-518. PMID 6253674 DOI: 10.1128/Jvi.36.2.506-518.1980  0.425
1980 Raab-Traub N, Dambaugh T, Kieff E. DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative. Cell. 22: 257-267. PMID 6253079 DOI: 10.1016/0092-8674(80)90173-7  0.41
1980 Dambaugh T, Beisel C, Hummel M, King W, Fennewald S, Cheung A, Heller M, Raab-Traub N, Kieff E. Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping. Proceedings of the National Academy of Sciences of the United States of America. 77: 2999-3003. PMID 6248879 DOI: 10.1073/Pnas.77.5.2999  0.371
1979 Kieff E, Given D, Powell ALT, King W, Dambaugh T, Raab-Traub N. Epstein-Barr virus: structure of the viral DNA and analysis of viral RNA in infected cells. Biochimica Et Biophysica Acta. 560: 355-373. PMID 228726 DOI: 10.1016/0304-419X(79)90009-X  0.455
1979 Given D, Kieff E. DNA of Epstein-Barr virus. VI. Mapping of the internal tandem reiteration. Journal of Virology. 31: 315-324. PMID 225556 DOI: 10.1128/Jvi.31.2.315-324.1979  0.328
1979 Given D, Yee D, Griem K, Kieff E. DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNA. Journal of Virology. 30: 852-862. PMID 225546 DOI: 10.1128/Jvi.30.3.852-862.1979  0.364
1979 Dambaugh T, Nkrumah FK, Biggar RJ, Kieff E. Epstein-Barr virus RNA in Burkitt tumor tissue Cell. 16: 313-322. PMID 222455 DOI: 10.1016/0092-8674(79)90008-4  0.354
1979 Powell ALT, King W, Kieff E. Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection. Journal of Virology. 29: 261-274. PMID 219221 DOI: 10.1128/Jvi.29.1.261-274.1979  0.356
1978 Given D, Kieff E. DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus. Journal of Virology. 28: 524-542. PMID 214576 DOI: 10.1128/Jvi.28.2.524-542.1978  0.364
1978 Raab-Traub N, Pritchett R, Kieff E. DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus. Journal of Virology. 27: 388-398. PMID 211267 DOI: 10.1128/Jvi.27.2.388-398.1978  0.335
1977 Hayward SD, Kieff E. DNA of Epstein-Barr virus. II. Comparison of the molecular weights of restriction endonuclease fragments of the DNA of Epstein-Barr virus strains and identification of end fragments of the B95-8 strain. Journal of Virology. 23: 421-9. PMID 196117 DOI: 10.1128/Jvi.23.2.421-429.1977  0.354
1977 Orellana T, Kieff E. Epstein-barr virus-specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive, and prooductive infections. Journal of Virology. 22: 321-330. PMID 194056 DOI: 10.1128/Jvi.22.2.321-330.1977  0.379
1976 Gerber P, Pritchett RF, Kieff ED. Antigens and DNA of a chimpanzee agent related to Epstein Barr virus Journal of Virology. 19: 1090-1099. PMID 184297 DOI: 10.1128/Jvi.19.3.1090-1099.1976  0.368
1976 Hayward SD, Kieff ED. Epstein Barr virus specific RNA. I. Analysis of viral RNA in cellular extracts and in the polyribosomal fraction of permissive and nonpermissive lymphoblastoid cell lines Journal of Virology. 18: 518-525. PMID 178893 DOI: 10.1128/Jvi.18.2.518-525.1976  0.421
1976 Dolyniuk M, Wolff E, Kieff E. Proteins of Epstein-Barr Virus. II. Electrophoretic analysis of the polypeptides of the nucleocapsid and the glucosamine- and polysaccharide-containing components of enveloped virus. Journal of Virology. 18: 289-297. PMID 176465 DOI: 10.1128/Jvi.18.1.289-297.1976  0.424
1976 Dolyniuk M, Pritchett R, Kieff E. Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus. Journal of Virology. 17: 935-949. PMID 176452 DOI: 10.1128/Jvi.17.3.935-949.1976  0.449
1976 Gerber P, Nkrumah FK, Pritchett R, Kieff E. Comparative studies of Epstein-Barr virus strains from Ghana and the United States. International Journal of Cancer. 17: 71-81. PMID 175023 DOI: 10.1002/Ijc.2910170111  0.421
1976 Pritchett R, Pedersen M, Kieff E. Complexity of EBV homologous DNA in continuous lymphoblastoid cell lines. Virology. 74: 227-231. DOI: 10.1016/0042-6822(76)90144-6  0.436
1975 Pritchett RF, Hayward SD, Kieff ED. DNA of Epstein Barr virus. I. Comparative studies of the DNA of Epstein Barr virus from HR 1 and B95 8 cells: size, structure, and relatedness Journal of Virology. 15: 556-569. PMID 163373 DOI: 10.1128/Jvi.15.3.556-559.1975  0.356
1974 Kieff E, Levine J. Homology between Burkitt herpes viral DNA and DNA in continuous lymphoblastoid cells from patients with infectious mononucleosis. Proceedings of the National Academy of Sciences of the United States of America. 71: 355-358. PMID 4360941 DOI: 10.1073/Pnas.71.2.355  0.417
1972 Kieff E, Hoyer B, Bachenheimer S, Roizman B. Genetic relatedness of type 1 and type 2 herpes simplex viruses. Journal of Virology. 9: 738-745. PMID 4337161 DOI: 10.1128/Jvi.9.5.738-745.1972  0.51
1971 Kieff ED, Bachenheimer SL, Roizman B. Size, composition, and structure of the deoxyribonucleic acid of herpes simplex virus subtypes 1 and 2 Journal of Virology. 8: 125-132. PMID 4329966 DOI: 10.1128/Jvi.8.2.125-132.1971  0.519
1971 Terni M, Caccialanza P, Cassai E, Kieff E. Aseptic Meningitis in Association with Herpes Progenitalis The New England Journal of Medicine. 285: 503-504. PMID 4326902 DOI: 10.1056/Nejm197108262850908  0.359
1971 Lee LF, Kieff ED, Bachenheimer SL, Roizman B, Spear PG, Burmester BR, Nazerian K. Size and composition of Marek's disease virus deoxyribonucleic acid. Journal of Virology. 7: 289-94. PMID 4101222 DOI: 10.1128/Jvi.7.3.289-294.1971  0.656
1969 Lee LF, Roizman B, Spear PG, Kieff ED, Burmester BR, Nazerian K. Marek's disease herpes virus: a cytomegalovirus. Proceedings of the National Academy of Sciences of the United States of America. 64: 952-6. PMID 4313336 DOI: 10.1073/Pnas.64.3.952  0.693
1968 Ejercito PM, Kieff ED, Roizman B. Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells Journal of General Virology. 2: 357-364. PMID 4300104 DOI: 10.1099/0022-1317-2-3-357  0.526
Show low-probability matches.